PMA supplement
BP090022 S004: Avioq HIV-1 Microelisa System
FDA PMA supplement · 30-Day Notice · Avioq, Inc.
Key facts
| Original PMA | BP090022 |
|---|---|
| Supplement number | S004 |
| Supplement type | 30-Day Notice |
| Trade name | Avioq HIV-1 Microelisa System |
| Generic name | Hiv detection test |
| Applicant | Avioq, Inc. |
| Product code | MZF |
| Received date | Apr 11, 2012 |
| Decision date | May 11, 2012 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: